Centre for Development of Advanced Computing (C-DAC), Pune University Campus, Pune, India.
J Mol Model. 2012 May;18(5):2117-33. doi: 10.1007/s00894-011-1228-8. Epub 2011 Sep 22.
Human ocular albinism type 1 protein (OA1)-a member of the G-protein coupled receptor (GPCR) superfamily-is an integral membrane glycoprotein expressed exclusively by intracellular organelles known as melanocytes, and is responsible for the proper biogenesis of melanosomes. Mutations in the Oa1 gene are responsible for the disease ocular albinism. Despite its clinical importance, there is a lack of in-depth understanding of its structure and mechanism of activation due to the absence of a crystal structure. In the present study, homology modeling was applied to predicting OA1 structure following thorough sequence analysis and secondary structure predictions. The predicted model had the signature residues and motifs expected of GPCRs, and was used for carrying out molecular docking studies with an endogenous ligand, L-DOPA and an antagonist, dopamine; the results agreed quite well with the available experimental data. Finally, three sets of explicit molecular dynamics simulations were carried out in lipid bilayer, the results of which not only confirmed the stability of the predicted model, but also helped witness some differences in structural features such as rotamer toggle switch, helical tilts and hydrogen bonding pattern that helped distinguish between the agonist- and antagonist-bound receptor forms. In place of the typical "D/ERY"-motif-mediated "ionic lock", a hydrogen bond mediated by the "DAY" motif was observed that could be used to distinguish the agonist and antagonist bound forms of OA1. In the absence of a crystal structure, this study helped to shed some light on the structural features of OA1, and its behavior in the presence of an agonist and an antagonist, which might be helpful in the future drug discovery process for ocular albinism.
人眼白化病 1 型蛋白(OA1)是 G 蛋白偶联受体(GPCR)超家族的成员,是一种仅在称为黑色素细胞的细胞内细胞器中表达的完整膜糖蛋白,负责黑素体的正确生物发生。Oa1 基因突变是眼白化病的病因。尽管其具有临床重要性,但由于缺乏晶体结构,因此对其结构和激活机制缺乏深入了解。在本研究中,通过彻底的序列分析和二级结构预测,应用同源建模来预测 OA1 结构。预测的模型具有 GPCR 预期的特征残基和基序,并用于与内源性配体 L-DOPA 和拮抗剂多巴胺进行分子对接研究;结果与可用的实验数据非常吻合。最后,在脂质双层中进行了三组显式分子动力学模拟,结果不仅证实了预测模型的稳定性,而且有助于观察到结构特征的一些差异,如旋转体切换、螺旋倾斜和氢键模式,有助于区分激动剂和拮抗剂结合的受体形式。在典型的“D/ERY”-基序介导的“离子锁”缺失的情况下,观察到由“DAY”基序介导的氢键,可用于区分 OA1 的激动剂和拮抗剂结合形式。在没有晶体结构的情况下,这项研究有助于揭示 OA1 的结构特征及其在激动剂和拮抗剂存在下的行为,这可能有助于未来眼白化病的药物发现过程。